Back
Barinthus Biotherapeutics PLC Stock Price Chart
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
33
BRNS
Barinthus Biotherapeutics PLC
Last Price:
$1.07
Seasonality Move:
-10.58%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and BRNS is experiencing selling pressure, which indicates risk of future bearish movement.
Barinthus Biotherapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Buy |
| 20-day SMA: | 0.96 | Buy |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.66 | Sell |
| 8-day EMA: | 0.98 | Buy |
| 20-day EMA: | 1 | Buy |
| 50-day EMA: | 1.1 | Sell |
| 200-day EMA: | 1.61 | Sell |
Barinthus Biotherapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 51.01 | Buy |
| Chaikin Money Flow: | -20427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.89 - 1.01) | Buy |
| Bollinger Bands (100): | (1.03 - 1.39) | Sell |
Barinthus Biotherapeutics PLC Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Barinthus Biotherapeutics PLC Stock
Is Barinthus Biotherapeutics PLC Stock a Buy?
-
Barinthus Biotherapeutics PLC share price is 1.04 while BRNS 8-day simple moving average is 0.95, which is a Buy signal.
-
The stock price of BRNS is 1.04 while Barinthus Biotherapeutics PLC 20-day SMA is 0.96, which makes it a Buy.
-
Barinthus Biotherapeutics PLC 50-day simple moving average is 1.16 while BRNS share price is 1.04, making it a Sell technically.
-
BRNS stock price is 1.04 and Barinthus Biotherapeutics PLC 200-day simple moving average is 1.66, creating a Sell signal.
BRNS Technical Analysis vs Fundamental Analysis
Sell
33
Barinthus Biotherapeutics PLC (BRNS)
is a Sell
Is Barinthus Biotherapeutics PLC a Buy or a Sell?
-
Barinthus Biotherapeutics PLC stock is rated a SellThe current Barinthus Biotherapeutics PLC [BRNS] share price is $1.04. The Score for BRNS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Barinthus Biotherapeutics PLC Stock Info
Market Cap:
41.8M
Price in USD:
1.04
Share Volume:
35.4K
Barinthus Biotherapeutics PLC 52-Week Range
52-Week High:
4.16
52-Week Low:
0.80
Sell
33
Barinthus Biotherapeutics PLC (BRNS)
is a Sell
Barinthus Biotherapeutics PLC Share Price Forecast
-
What is the Barinthus Biotherapeutics PLC stock price today?The Barinthus Biotherapeutics PLC stock price is 1.04 USD today.
-
Will BRNS stock go up or go down?Barinthus Biotherapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Barinthus Biotherapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Barinthus Biotherapeutics PLC is overvalued.
Is Barinthus Biotherapeutics PLC Stock a Buy?
-
Barinthus Biotherapeutics PLC share price is 1.04 while BRNS 8-day exponential moving average is 0.98, which is a Buy signal.
-
The stock price of BRNS is 1.04 while Barinthus Biotherapeutics PLC 20-day EMA is 1.00, which makes it a Buy.
-
Barinthus Biotherapeutics PLC 50-day exponential moving average is 1.10 while BRNS share price is 1.04, making it a Sell technically.
-
BRNS stock price is 1.04 and Barinthus Biotherapeutics PLC 200-day simple moving average is 1.61, creating a Sell signal.
Fundamental Analysis of Barinthus Biotherapeutics PLC
Is Barinthus Biotherapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Barinthus Biotherapeutics PLC
Should I short Barinthus Biotherapeutics PLC stock?
-
BRNS Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Barinthus Biotherapeutics PLC is a Sell
-
Barinthus Biotherapeutics PLC Relative Strength Index (RSI) is 51.01, which suggest Barinthus Biotherapeutics PLC is overbought
-
The Bollinger Bands (25) for Barinthus Biotherapeutics PLC is (0.89 - 1.01), which suggest Barinthus Biotherapeutics PLC is a Sell
-
The Bollinger Bands (100) for Barinthus Biotherapeutics PLC is (1.03 - 1.39), which suggest Barinthus Biotherapeutics PLC is a Sell
* Barinthus Biotherapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.